tiprankstipranks
Trending News
More News >
Heranba Industries Limited (IN:HERANBA)
:HERANBA
India Market
Advertisement

Heranba Industries Limited (HERANBA) AI Stock Analysis

Compare
1 Followers

Top Page

IN:HERANBA

Heranba Industries Limited

(HERANBA)

Rating:48Neutral
Price Target:
₹335.00
▼(-0.96% Downside)
Heranba Industries Limited faces significant challenges, primarily due to its high P/E ratio and cash flow issues, which weigh heavily on its valuation and financial performance scores. Technical indicators suggest a bearish trend, further impacting the overall score. The absence of earnings call insights and corporate events leaves these areas unaddressed.

Heranba Industries Limited (HERANBA) vs. iShares MSCI India ETF (INDA)

Heranba Industries Limited Business Overview & Revenue Model

Company DescriptionHeranba Industries Limited (HERANBA) is a prominent agrochemical company based in India, specializing in the production and distribution of a wide array of crop protection chemicals, including insecticides, herbicides, fungicides, and public health products. The company operates across various sectors, with a focus on helping the agricultural community enhance crop yield and quality through effective pest management solutions.
How the Company Makes MoneyHeranba Industries Limited makes money through the manufacturing and sale of agrochemical products. Key revenue streams include domestic sales of crop protection chemicals to farmers and agricultural businesses, as well as exports to international markets. The company leverages its extensive distribution network to reach a broad customer base, including partnerships with distributors and dealers. Additionally, Heranba benefits from its investment in research and development, allowing it to introduce new and innovative products that meet the evolving needs of the agricultural industry.

Heranba Industries Limited Financial Statement Overview

Summary
Heranba Industries Limited shows a mixed financial performance. While there is stability in some balance sheet metrics, income statement and cash flow challenges suggest operational inefficiencies and cash generation issues. The company should focus on improving profitability margins and cash flow management to ensure sustainable financial health.
Income Statement
55
Neutral
Heranba Industries Limited demonstrated a volatile revenue and profit trajectory. The revenue growth rate has been inconsistent, with a notable decline in 2025 compared to 2024. Gross profit margins have been relatively stable, but the net profit margin significantly declined from 2024 to 2025, indicating increased operational challenges. The EBIT margin also decreased, reflecting potential inefficiencies. However, the EBITDA margin remained positive, suggesting some resilience in operational cash generation.
Balance Sheet
65
Positive
The company maintains a healthy equity position with an increasing total assets base. The debt-to-equity ratio is moderate, indicating balanced leverage, though debt levels have increased over the years. Return on equity has dropped significantly, indicating reduced profitability. The equity ratio remains strong, suggesting stability and lower financial risk.
Cash Flow
45
Neutral
Free cash flow has been negative in recent years, highlighting challenges in cash generation after capital expenditures. The operating cash flow to net income ratio suggests operational cash generation issues, as seen in the declining operating cash flows. The free cash flow to net income ratio is also unfavorable, indicating that net income is not translating into free cash flow effectively.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2020
Income Statement
Total Revenue14.13B14.17B12.49B13.19B14.35B12.02B
Gross Profit4.31B4.72B3.70B4.37B5.04B4.23B
EBITDA1.04B1.05B893.40M1.68B2.79B2.28B
Net Income28.80M30.70M348.90M1.04B1.89B1.54B
Balance Sheet
Total Assets18.13B18.13B14.80B11.62B10.69B8.43B
Cash, Cash Equivalents and Short-Term Investments545.60M545.60M395.50M1.22B1.05B867.77M
Total Debt3.49B3.49B1.65B930.00M539.62M511.35M
Total Liabilities9.63B9.63B6.27B3.52B3.54B3.15B
Stockholders Equity8.41B8.41B8.43B8.10B7.14B5.28B
Cash Flow
Free Cash Flow0.00-1.75B-1.46B611.90M176.37M362.99M
Operating Cash Flow0.001.01B1.07B1.23B981.75M603.99M
Investing Cash Flow0.00-2.39B-2.41B-1.00B-816.79M-407.13M
Financing Cash Flow0.001.52B620.20M-180.80M-62.80M619.00M

Heranba Industries Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price338.25
Price Trends
50DMA
359.55
Negative
100DMA
317.51
Positive
200DMA
331.93
Positive
Market Momentum
MACD
-1.81
Positive
RSI
44.30
Neutral
STOCH
34.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:HERANBA, the sentiment is Negative. The current price of 338.25 is below the 20-day moving average (MA) of 347.98, below the 50-day MA of 359.55, and above the 200-day MA of 331.93, indicating a neutral trend. The MACD of -1.81 indicates Positive momentum. The RSI at 44.30 is Neutral, neither overbought nor oversold. The STOCH value of 34.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:HERANBA.

Heranba Industries Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
₹92.36B22.00
0.94%36.53%184.15%
72
Outperform
₹23.96B15.99
0.61%2.61%24.65%
70
Outperform
₹284.91B51.14
0.21%13.78%28.22%
69
Neutral
₹74.81B24.46
0.12%9.92%19.92%
63
Neutral
₹69.47B40.39
0.69%7.10%29.32%
61
Neutral
$10.27B6.370.76%2.91%3.10%-36.03%
48
Neutral
₹13.53B461.09
0.35%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:HERANBA
Heranba Industries Limited
338.25
-155.15
-31.45%
IN:DHANUKA
Dhanuka Agritech Limited
1,613.15
-43.83
-2.65%
IN:INSECTICID
Insecticides (India) Limited
814.85
-145.60
-15.16%
IN:RALLIS
Rallis India Limited
361.50
22.46
6.62%
IN:SHARDACROP
Sharda Cropchem Ltd.
903.00
360.24
66.37%
IN:SUMICHEM
Sumitomo Chemical India Ltd.
584.05
68.15
13.21%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 05, 2025